Results 121 to 130 of about 9,215 (199)

Antibody-Radionuclide Conjugates for Solid Tumors: Multidimensional Strategies from Component Engineering to Synergistic Combination Therapy. [PDF]

Int J Mol Sci
Zhao M, Zhao X, Gao Z, Shao R, Liu L, Zhao W.   +5 more
europepmc   +1 more source

Selective Chemistry Enables Simultaneous ImmunoPET and Radioimmunotherapy with a Dual-Labeled Probe. [PDF]

JACS Au
Kao WM, Grimaldi C, Samuels ZV, Dehlavi G, Strugala E, Cornejo M, Sebastiano J, Carter LM, Zeglis BM.   +8 more
europepmc   +1 more source

Optimizing the timing of JAK1 inhibition preserves the anti-tumor efficacy of radioimmunotherapy in lung cancer by preventing T cell exhaustion. [PDF]

Exp Hematol Oncol
Gao Z, Yang L, Wang L.
europepmc   +1 more source

Radionuclide-labeled oxygen-self-supplying calcium reservoir for high-efficiency radioimmunotherapy via synergistic pyroptosis activation and PD-L1 downregulation. [PDF]

J Nanobiotechnology
Liu L, Huang K, Guo H, He L, Wang X, Wang C, Lin J, Huang N, Miao W.   +8 more
europepmc   +1 more source

A senescence-associated gene signature predicts radiotherapy prognosis in non-small cell lung cancer and identifies CSF1 as a target to potentiate radioimmunotherapy. [PDF]

Biol Direct
Liu S, Zhang Y, Li L, Wang H, Yuan H, Zhang D, Zhao D, Guan Y, Yuan Z.   +8 more
europepmc   +1 more source

Delta-like Ligand 3-Directed ²²⁵Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models. [PDF]

J Nucl Med
Hoang TT, Bauer D, Ingham A, Miranda IC, Carter LM, Michel A, De Gregorio R, Welk J, Zhong H, Poirier JT, Morris MJ, Bodei L, Rudin CM, Tendler S, Lewis JS.   +14 more
europepmc   +1 more source

Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities. [PDF]

J Nucl Med
Wahl RL, Dewaraja YK.
europepmc   +1 more source

Evaluation of the abscopal-like effect of radioimmunotherapy on sentinel lymph nodes in H22 hepatocellular carcinoma via dynamic lymphography. [PDF]

BMC Cancer
Wang H, Chen D, Liu Z, Zhao X, Zhang J, Zhang D.   +5 more
europepmc   +1 more source

Synergistic effects and clinical utilization of radioimmunotherapy for brain metastases from driver mutation-negative non-small cell lung cancer. [PDF]

Precis Radiat Oncol
Yu S, Ni J, Chen H, Weng N, Yang X, Chu X, Chu L, Zhu Z.   +7 more
europepmc   +1 more source